tiprankstipranks
Advertisement
Advertisement

SE:ORX Stock Latest News

Orexo updates share and voting structure after class C conversion
Company AnnouncementsOrexo updates share and voting structure after class C conversion
9d ago
Orexo Calls 2026 AGM to Decide on Governance, Capital Measures and Incentive Plan
PremiumCompany Announcements
Orexo Calls 2026 AGM to Decide on Governance, Capital Measures and Incentive Plan
10d ago
Orexo Publishes 2025 Annual and Sustainability Reports Detailing Strategy and Market Position
PremiumCompany Announcements
Orexo Publishes 2025 Annual and Sustainability Reports Detailing Strategy and Market Position
13d ago
Orexo Restructures Leadership to Drive Pipeline and AmorphOX-Focused Growth
PremiumCompany Announcements
Orexo Restructures Leadership to Drive Pipeline and AmorphOX-Focused Growth
1M ago
Orexo to Redeem SEK 500m Social Bonds After Zubsolv Rights Sale
PremiumCompany Announcements
Orexo to Redeem SEK 500m Social Bonds After Zubsolv Rights Sale
1M ago
Orexo Adjusts Share Structure After U.S. Zubsolv Divestment
PremiumCompany AnnouncementsOrexo Adjusts Share Structure After U.S. Zubsolv Divestment
2M ago
Orexo Boosts Cash and Earnings After USD 91 Million Zubsolv US Sale
Premium
Company Announcements
Orexo Boosts Cash and Earnings After USD 91 Million Zubsolv US Sale
2M ago
Orexo to Present New Strategy and AmorphOX Pipeline at March R&D Day
Premium
Company Announcements
Orexo to Present New Strategy and AmorphOX Pipeline at March R&D Day
2M ago
Orexo to Present 2025 Full-Year Results with Focus on Zubsolv US Divestment
PremiumCompany Announcements
Orexo to Present 2025 Full-Year Results with Focus on Zubsolv US Divestment
3M ago
Orexo Completes Zubsolv US Rights Deal With Dexcel to Refocus on AmorphOX Pipeline
PremiumCompany Announcements
Orexo Completes Zubsolv US Rights Deal With Dexcel to Refocus on AmorphOX Pipeline
3M ago
Orexo Sells US Rights to Zubsolv to Dexcel to Repay Debt and Fund AmorphOX Pipeline
PremiumCompany Announcements
Orexo Sells US Rights to Zubsolv to Dexcel to Repay Debt and Fund AmorphOX Pipeline
4M ago
Orexo AB’s Earnings Call: R&D Gains Amid Financial Hurdles
PremiumCompany Announcements
Orexo AB’s Earnings Call: R&D Gains Amid Financial Hurdles
6M ago
Orexo AB Reports Q3 2025 Earnings and Strategic Developments
PremiumCompany AnnouncementsOrexo AB Reports Q3 2025 Earnings and Strategic Developments
6M ago
Orexo AB Reports Q3 2025 Financials and Secures BARDA Award
Premium
Company Announcements
Orexo AB Reports Q3 2025 Financials and Secures BARDA Award
6M ago
ORXOF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ORXOF Upcoming Earnings Report: What to Expect?
6M ago
Orexo AB Announces Nomination Committee for 2026 AGM
PremiumCompany Announcements
Orexo AB Announces Nomination Committee for 2026 AGM
6M ago
Orexo AB to Present Q3 2025 Interim Report and Project Updates
PremiumCompany Announcements
Orexo AB to Present Q3 2025 Interim Report and Project Updates
6M ago
Orexo AB Enhances R&D with Strategic Move to Uppsala Science Park
PremiumCompany Announcements
Orexo AB Enhances R&D with Strategic Move to Uppsala Science Park
6M ago
Orexo Secures $8 Million for OX390 Development from BARDA
PremiumCompany Announcements
Orexo Secures $8 Million for OX390 Development from BARDA
6M ago
Orexo AB to Participate in Pareto Securities’ 16th Annual Healthcare Conference
PremiumCompany AnnouncementsOrexo AB to Participate in Pareto Securities’ 16th Annual Healthcare Conference
7M ago
Orexo’s AmorphOX Technology Shows Promise for Intranasal GLP-1 Medication
Premium
Company Announcements
Orexo’s AmorphOX Technology Shows Promise for Intranasal GLP-1 Medication
7M ago
Orexo AB Reports Q2 2025 Financial Results
Premium
Company Announcements
Orexo AB Reports Q2 2025 Financial Results
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >